4 research outputs found
General Last-Step Labeling of Biomolecule-Based Substrates by [<sup>12</sup>C], [<sup>13</sup>C], and [<sup>11</sup>C] Carbon Monoxide
Alkaloid-, steroid-,
biotin-, carbohydrate-, nucleoside-, and peptide-based
bioconjugates are easily labeled with CO by a last-step palladium-catalyzed
carbonylation. The choice of the [<sup>12</sup>C], [<sup>13</sup>C],
or [<sup>11</sup>C] isotope opens the way to a new class of potential
tracers or ligands easily available for various applications
Diastereoselective Three-Component Vinylogous Mannich Reaction of Nitrogen Heterocycles, Acyl/Sulfonyl Chlorides, and Silyloxyfurans/pyrroles
A one-step,
3-component vinylogous Mannich reaction of trimethylsilyloxyfuran
or <i>N</i>-protected <i>tert</i>-butyldimethylsilyloxypyrrole
with a variety of nitrogen-containing heterocycles in the presence
of diverse electrophiles is described. The reaction products were
generally obtained in high yields and as a single diastereoisomer
having the (<i>R</i>*,<i>R</i>*) relative configuration
based on crystallographic studies of several derivatives. Several
azaheterocycles were successfully used for this reaction, such as
isoquinolines, quinoline, phenanthridine, quinazoline, phthalazine,
and Ī²-carboline, and electrophiles included acetyl chloride,
methyl chloroformate, methyl chloromalonate, 2-bromobutanoyl chloride,
and arylsulfonyl chlorides. The products of the vinylogous Mannich
reactions were subjected to further transformations, leading to highly
functionalized and stereochemically defined tetracyclic derivatives
that are valuable building blocks for the preparation of natural products
or medicinal agents
Diastereoselective Three-Component Vinylogous Mannich Reaction of Nitrogen Heterocycles, Acyl/Sulfonyl Chlorides, and Silyloxyfurans/pyrroles
A one-step,
3-component vinylogous Mannich reaction of trimethylsilyloxyfuran
or <i>N</i>-protected <i>tert</i>-butyldimethylsilyloxypyrrole
with a variety of nitrogen-containing heterocycles in the presence
of diverse electrophiles is described. The reaction products were
generally obtained in high yields and as a single diastereoisomer
having the (<i>R</i>*,<i>R</i>*) relative configuration
based on crystallographic studies of several derivatives. Several
azaheterocycles were successfully used for this reaction, such as
isoquinolines, quinoline, phenanthridine, quinazoline, phthalazine,
and Ī²-carboline, and electrophiles included acetyl chloride,
methyl chloroformate, methyl chloromalonate, 2-bromobutanoyl chloride,
and arylsulfonyl chlorides. The products of the vinylogous Mannich
reactions were subjected to further transformations, leading to highly
functionalized and stereochemically defined tetracyclic derivatives
that are valuable building blocks for the preparation of natural products
or medicinal agents
Last-Step Pd-Mediated [<sup>11</sup>C]CO Labeling of a Moxestrol-Conjugated <i>o</i>āIodobenzyl Alcohol: From Model Experiments to in Vivo Positron Emission Tomography Studies
The fast, efficient,
and functional group tolerant last-step radiolabeling
of bioconjugates is crucial for positron emission tomography (PET)
applications. In this context, <i>o</i>-iodobenzyl alcohol
based structures were identified as ideal tags for an easy Pd-catalyzed
carbonylation after bioconjugation, and a moxestrol-conjugated precursor
was chosen as the model compound for the further studies. Despite
scale and time constraints, conditions developed with [<sup>12</sup>C]ĀCO and [<sup>13</sup>C]ĀCO were easily transferred to the <sup>11</sup>C isotope, and the desired radioactive product was obtained in amounts
up to 740 MBq with radiochemical purities higher than 99%. Radio-high-performance
liquid chromatography analyses of rat blood samples demonstrated excellent
in vivo stability within the time of the acquisition. MicroPETāmagnetic
resonance imaging showed excretion pathways similar to moxestrol,
and molecular modeling was also performed to evaluate the potential
ability of this conjugate to bind estrogen receptors Ī±. Thus,
being both synthetically and biologically suitable, this strategy
clears the path to potential novel biotracers for preclinical PET
imaging